Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X

Data from from Tufts and Medable reveal on average, decentralized clinical trials (DCTs) are associated with reduced clinical trial timelines

Related Keywords

Pamela Tenaerts ,Joseph Dimasi ,Study Of Drug Development ,Medable Inc ,Tufts Center ,Tufts University School Of Medicine ,Decentralized Clinical Trials ,Should Know ,Drug Development ,Tufts University School ,Chief Scientific Officer ,